Table 10. Results obtained from the examination of UGV-2, S5-like and TSMV-2 specific S-segments by RT-PCR and UGV-1, UHV-1 NP and UHV-1 NP-C specific IgY and IgM antibodies by ELISA—Animals with BIBD.
RT-PCR | UGV-1 | UHV-1 NP | UHV-1 NP-C | ||||||
---|---|---|---|---|---|---|---|---|---|
IgY | IgM n = 33 tested | IgY and IgM n = 33 tested | IgY | IgM | IgY and IgM | IgY | IgM | IgY and IgM | |
Positive 34/34 (100%) |
Pos 9/34 (26.47%) |
Pos 19/33 (57.58%) |
Pos 7/33 (21.21%) |
Pos 6/34 (17.65%) | Pos 7/34 (20.59%) | Pos 4/34 (11.76%) |
Pos 7/34 (20.59%) | Pos 10/34 (29.41%) | Pos 5/34 (14.71%) |
Neg 25/34 (73.53%) | Neg 14/33 (42.42%) |
Neg 13/33 (39.39%) |
Neg 28/34 (82.35%) | Neg 27/34 (79.41%) | Neg 25/34 (73.53%) |
Neg 27/34 (79.41%) | Neg 24/34 (70.59%) | Neg 22/34 (64.71%) |
|
3 Segments 23/34 (67.65%) | Pos 6/23 (26.09%) |
Pos 14/22 (63.64%) |
Pos 4/22 (18.18%) |
Pos 2/23 (8.7%) | Pos 4/23 (17.39%) | Pos 1/23 (4.35%) |
Pos 3/23 (13.04%) | Pos 7/23 (30.43%) | Pos 2/23 (8.7%) |
Neg 17/23 (73.91%) | Neg 8/22 (36.36%) |
Neg 7/22 (31.82%) |
Neg 21/23 (91.3%) | Neg 19/23 (82.61%) | Neg 18/23 (78.26%) |
Neg 20/23 (86.96%) | Neg 16/23 (69.57%) | Neg 15/23 (65.22%) |
|
2 Segments 9/34 (26.47%) |
Pos 2/9 (22.22%) |
Pos 3/9 (33.33%) |
Pos 2/9 (22.22%) |
Pos 3/9 (33.33%) | Pos 2/9 (22.22%) | Pos 2/9 (22.22%) |
Pos 3/9 (33.33%) | Pos 2/9 (22.22%) | Pos 2/9 (22.22%) |
Neg 7/9 (77.78%) |
Neg 6/9 (66.67%) |
Neg 6/9 (66.67%) |
Neg 6/9 (66.67%) | Neg 7/9 (77.78%) | Neg 6/9 (66.67%) |
Neg 6/9 (66.67%) | Neg 7/9 (77.78%) | Neg 6/9 (66.67%) |
|
1 Segment 2/34 (5.88%) |
Pos 1/2 (50%) |
Pos 2/2 (100%) |
Pos 1/2 (50%) |
Pos 1/2 (50%) |
Pos 1/2 (50%) |
Pos 1/2 (50%) |
Pos 1/2 (50%) |
Pos 1/2 (50%) |
Pos 1/2 (50%) |
Neg 1/2 (50%) |
Neg 0/2 (0%) |
Neg 0/2 (0%) |
Neg 1/2 (50%) |
Neg 1/2 (50%) |
Neg 1/2 (50%) |
Neg 1/2 (50%) |
Neg 1/2 (50%) |
Neg 1/2 (50%) |
Pos–positive; Neg—negative